Interactions of monovalent cations with sodium channels in squid axon. I. Modification of physiological inactivation gating.
Inactivation of Na channels has been studied in voltage-clamped, internally perfused squid giant axons during changes in the ionic composition of the intracellular solution. Peak Na currents are reduced when tetramethylammonium ions (TMA+) are substituted for Cs ions internally. The reduction reflects a rapid, voltage-dependent block of a site in the channel by TMA+. The estimated fractional electrical distance for the site is 10% of the channel length from the internal surface. Na tail currents are slowed by TMA+ and exhibit kinetics similar to those seen during certain drug treatments. Steady state INa is simultaneously increased by TMA+, resulting in a "cross-over" of current traces with those in Cs+ and in greatly diminished inactivation at positive membrane potentials. Despite the effect on steady state inactivation, the time constants for entry into and exit from the inactivated state are not significantly different in TMA+ and Cs+. Increasing intracellular Na also reduces steady state inactivation in a dose-dependent manner. Ratios of steady state INa to peak INa vary from approximately 0.14 in Cs+- or K+-perfused axons to approximately 0.4 in TMA+- or Na+-perfused axons. These results are consistent with a scheme in which TMA+ or Na+ can interact with a binding site near the inner channel surface that may also be a binding or coordinating site for a natural inactivation particle. A simple competition between the ions and an inactivation particle is, however, not sufficient to account for the increase in steady state INa, and changes in the inactivation process itself must accompany the interaction of TMA+ and Na+ with the channel.
Oxford
G S
GS
Yeh
J Z
JZ
D000818:Animals; D001369:Axons / Q000378:metabolism*; D002414:Cations, Monovalent / Q000494:pharmacology; D002586:Cesium / Q000494:pharmacology*; D004553:Electric Conductivity; D007473:Ion Channels / Q000187:drug effects* / Q000502:physiology; D007700:Kinetics; D010477:Perfusion; D011188:Potassium / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012964:Sodium / Q000037:antagonists & inhibitors / Q000378:metabolism*
D002414:Cations, Monovalent; D007473:Ion Channels; D000644:Quaternary Ammonium Compounds; D002586:Cesium; D012964:Sodium; D011402:Pronase; C027917:tetramethylammonium; D011188:Potassium